Buse, D. C., Versijpt, J., & Diener, H. (2025). Disrupting Migraine Dynamics: A Narrative Review of the Consequences of Modern Anti-CGRP Monoclonal Antibody Therapies. Neurology & Therapy, 14(4), 1185. https://doi.org/10.1007/s40120-025-00769-z
Chicago Style (17th ed.) CitationBuse, Dawn C., Jan Versijpt, and Hans-Christoph Diener. "Disrupting Migraine Dynamics: A Narrative Review of the Consequences of Modern Anti-CGRP Monoclonal Antibody Therapies." Neurology & Therapy 14, no. 4 (2025): 1185. https://doi.org/10.1007/s40120-025-00769-z.
MLA (9th ed.) CitationBuse, Dawn C., et al. "Disrupting Migraine Dynamics: A Narrative Review of the Consequences of Modern Anti-CGRP Monoclonal Antibody Therapies." Neurology & Therapy, vol. 14, no. 4, 2025, p. 1185, https://doi.org/10.1007/s40120-025-00769-z.